Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CLPT Relative to the S&P 500

CLPT Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the ClearPoint Neuro, Inc. (NASD:CLPT) seasonal charts above shows that a Buy Date of December 15 and a Sell Date of April 15 has resulted in a geometric average return of 11.52% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 33.85% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company’s ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company’s products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.

To download CLPT seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CLPT